ArticleThe Journal of organic chemistry2026
On-Resin Synthesis and Diversification of Macrocyclic Disulfide Bridge Peptidomimetics via Bifunctional 5-Iodo-1,4-Triazoles.
Article in The Journal of organic chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cyclic peptides represent an important class of therapeutic molecules, however, often require late-stage functionalization to address suboptimal pharmacokinetic properties. Solid phase bifunctional cyclization strategies that enable both macrocyclization and diversification within a single scaffold remain limited. Herein, we report a general on-resin platform that exploits the 5-iodo-1,4-triazole as a bifunctional macrocyclic disulfide bridge mimetic, enabling modular late-stage modification of cyclic peptides. The methodology was demonstrated across a diverse panel of peptides spanning 6-12 residue macrocycles, incorporating varied amino acid side chains, N-terminal protecting groups, and peptide topologies. Formation of the 5-iodo-1,4-triazole was compatible with functionally diverse sequences under Fmoc-based solid-phase peptide synthesis conditions, highlighting the robustness of the cyclization strategy. Optimization of on-resin Suzuki-Miyaura cross-coupling significantly reduced reaction times while maintaining high conversions, enabling efficient aryl diversification of the triazole linkage. To expand structural scope, a complementary on-resin Sonogashira cross-coupling protocol was developed, allowing direct installation of alkyl linkers, functional handles, and biologically relevant motifs that are inaccessible through aryl-based cross-coupling alone. Together, these orthogonal palladium-catalyzed transformations establish a unified, operationally simple platform for the synthesis and late-stage diversification of cyclic peptidomimetics, providing rapid access to structurally diverse macrocyclic peptides relevant to chemical biology and medicinal chemistry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.